Page 5 - Tscan Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tscan therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tscan Therapeutics Inc Today - Breaking & Trending Today

TScan Therapeutics (NASDAQ:TCRX) Given Outperform Rating at Wedbush

Wedbush restated their outperform rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note published on Wednesday morning, RTT News reports. The firm currently has a $10.00 target price on the stock. Wedbush also issued estimates for TScan Therapeutics’ Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.23) EPS, […] ....

United States , Tscan Therapeutics Company Profile , Renaissance Technologies , Tscan Therapeutics Inc , Blackrock Inc , Free Report , Therapeutics Stock , Get Free Report , Jane Street Group , Therapeutics Company , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Reiterated Rating ,

TScan Therapeutics Announces Closing of Upsized Public Offering

WALTHAM, Mass., April 19, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment. ....

United States , New York , Heather Savelle , Maghan Meyers , Exchange Commission , Tscan Therapeutics Inc , Prospectus Department , Morgan Stanley Co , Globe Newswire Tscan Therapeutics Inc , Morgan Stanley , Needham Company , Td Securities United States , Securities Exchange , Hc Wainwright Co , Nasdaq Global Market , Sci Capital , Private Securities Litigation Reform Act , Annual Report , Securities Exchange Act ,

TScan Therapeutics Announces Closing of Upsized Public

WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the. ....

United States , New York , Heather Savelle , Maghan Meyers , Exchange Commission , Tscan Therapeutics Inc , Prospectus Department , Td Securities United States , Needham Company , Morgan Stanley Co , Securities Exchange , Hc Wainwright Co , Globe Newswire Tscan Therapeutics Inc , Morgan Stanley , Nasdaq Global Market , Sci Capital , Private Securities Litigation Reform Act , Annual Report , Securities Exchange Act , Nasdaq Tcrx , Tscan Therapeutics ,

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

Dr. Louis brings to TScan extensive experience in cell therapy, medical affairs, and clinical and commercial developmentWALTHAM, Mass., April 08, 2024 TScan Therapeutics, Inc. , a clinical-stage. ....

Baylor College Of Medicine , United States , Chrystalu Louis , Melissa Forst , Heather Savelle , Gavin Macbeath , Debora Barton , Southwestern University At Georgetown , Professor At Texas Children Cancer Center , Globe Newswire Tscan Therapeutics Inc , Zentalis Pharmaceuticals , Bristol Myers Squibb Company , Tulane University School Of Public Health , Securities Exchange , Tulane University School Of Medicine , Tscan Therapeutics Inc , Masters Degree In Public Health , Hematology Service , Merrimack Pharmaceuticals , Chief Medical , Chief Executive , Chief Medical Officer , Assistant Professor , Texas Children , Cancer Center , Baylor College ,

Head to Head Review: TScan Therapeutics (NASDAQ:TCRX) & Zura Bio (NASDAQ:ZURA)

TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Zura Bio (NASDAQ:ZURA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership. Insider & Institutional Ownership 82.8% of TScan […] ....

United States , Zura Bio , Novartis Institutes For Biomedical Research Inc , Tscan Therapeutics Inc , Get Free Report , Given Zura Bio , Novartis Institutes , Biomedical Research , Bio Limited , Therapeutics Daily ,